Centene to offer Obamacare in 3 more states, expand in Indiana
Health insurer Centene Corp. plans a broad expansion of its Obamacare offerings next year at a time when many of its big rivals are retreating from the program.
Health insurer Centene Corp. plans a broad expansion of its Obamacare offerings next year at a time when many of its big rivals are retreating from the program.
In statehouses across the country and in Congress, drugmaker Alkermes is pushing its own addiction treatment while contributing to misconceptions and stigma about other medications used to treat opioid addiction.
The court's unanimous ruling Monday means a loss of billions in sales to makers of original versions of biologic drugs.
Besides contributing to overdoses, abuse of Opana ER was blamed for a 2015 outbreak of HIV and hepatitis C in southern Indiana linked to sharing needles, according to the FDA.
Just weeks after abandoning its proposed $48 billion merger with rival Cigna Corp., the Indianapolis-based health insurer is looking for its next deal. But this time, it is likely to be much smaller.
Around Indiana, hospitals are doubling down on the lofty goal of patient satisfaction. Some, like IU Health, are hiring managers to oversee various aspects of the patient experience, from registration to discharge.
The loss of another insurer in the program would put more pressure on Republicans in Congress who are attempting to repeal and replace large parts of Obamacare.
Planned Parenthood of Indiana and Kentucky Inc. on Tuesday announced the hiring of a veteran not-for-profit leader to replace Betty Cockrum, who is retiring after 15 years as president and CEO of the organization.
Religious hospitals don't have to comply with federal laws protecting pension plans, a unanimous Supreme Court ruled Monday in a case that affects retirement benefits for roughly a million workers.
The first case against Bloomington-based Cook Group from patients who say the company’s blood-clot filters malfunctioned is headed for trial this fall in Indianapolis.
Prosecutors argue that subpoenas issued by counsel for the nursing home company's former CEO are overly broad and "an abuse of process."
Rice, 52, who had been the company's top finance officer since 2006, is one of the most powerful black executives in corporate America. He had been widely considered a leading candidate to succeed CEO John Lechleiter, but that position went to fellow Lilly executive Dave Ricks.
Top pharmaceutical CEOs say they expect President Donald Trump, a frequent critic of industry pricing practices, to take steps soon to address high U.S. drug costs.
For the first time since its founding in 1996, the Women’s Fund of Central Indiana is supporting an initiative that’s not exclusive to females.
Bio-Response Solution’s flagship product liquefies human corpses, turning muscle, flesh and fat into a coffee-colored effluent that can be swirled down the drain.
Indiana ranks 44th nationwide in the capacity to meet the medication-assisted treatment needs of our population.
LifeOmic is seeking to help doctors provide more precise treatments for patients by sequencing their DNA.
People shopping for insurance through the Affordable Care Act in yet more regions could be facing higher prices and fewer choices next year. A new report shows Affordable Care Act premiums have soared since 2013.
Roche Group is rolling out a new blood-glucose meter and a savings program for test strips, which it says it will make diabetes care more affordable.
After several years in which the value of its assets swelled, philanthropic giant Lilly Endowment Inc. watched its coffers shrink 12.7 percent in 2016 from about $11.8 billion to $10.3 billion.